These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 18403218

  • 1. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
    Ruessmann HJ, German Society of out patient diabetes centres AND (Arbeitsgemeinschaft niedergelassener diabetologisch tätiger Arzte e.V.).
    J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE, Gordon A, Vera-Llonch M, Dukes E, Rousseau C.
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [Abstract] [Full Text] [Related]

  • 3. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
    Pérez C, Navarro A, Saldaña MT, Masramón X, Rejas J.
    Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
    [Abstract] [Full Text] [Related]

  • 4. Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy.
    Udall M, Harnett J, Mardekian J.
    J Med Econ; 2012 Jul; 15(2):361-70. PubMed ID: 22181052
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
    Rudroju N, Bansal D, Talakokkula ST, Gudala K, Hota D, Bhansali A, Ghai B.
    Pain Physician; 2013 Jul; 16(6):E705-14. PubMed ID: 24284851
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy.
    Ko SH, Kwon HS, Yu JM, Baik SH, Park IB, Lee JH, Ko KS, Noh JH, Kim DS, Kim CH, Mok JO, Park TS, Son HS, Cha BY.
    Diabet Med; 2010 Sep; 27(9):1033-40. PubMed ID: 20722677
    [Abstract] [Full Text] [Related]

  • 17. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
    Bellows BK, Nelson RE, Oderda GM, LaFleur J.
    Pain; 2016 Jan; 157(1):203-213. PubMed ID: 26397932
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of the antinociceptive interactions in two-drug combinations of gabapentin, oxcarbazepine and amitriptyline in streptozotocin-induced diabetic mice.
    Tomić MA, Vucković SM, Stepanović-Petrović RM, Micov AM, Ugresić ND, Prostran MS, Bosković B.
    Eur J Pharmacol; 2010 Feb 25; 628(1-3):75-82. PubMed ID: 19917280
    [Abstract] [Full Text] [Related]

  • 20. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia.
    O'Connor AB, Noyes K, Holloway RG.
    J Am Geriatr Soc; 2007 Aug 25; 55(8):1176-84. PubMed ID: 17661955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.